Skin changes are common with age, and moles are often benign. However, melanoma, a severe skin cancer, can resemble a mole.

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

Topline data were announced from a phase 3 trial evaluating tarlatamab for the treatment of SCLC in patients who progressed on or after a single line of platinum-based chemotherapy.

Zevaskyn, which Abeona priced at $3.1 million, treats epidermolysis bullosa. It will compete with a gene therapy from Krystal ...

DNA detection at baseline was associated with worse recurrence-free, overall survival in BRAFV600-mutant stage III melanoma.